ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• Guggenheim Reiterates Neutral Rating on CrowdStrike (CRWD)
• Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c